No axillary lymph node dissection

OTHER2 trials

Sponsors

ETOP IBCSG Partners Foundation, Institut Paoli-Calmettes

Conditions

Breast CancerInvasive Breast Cancer

Unknown Phase

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases

CompletedNCT00072293

ETOP IBCSG Partners FoundationBreast Cancer

Start: 2001-12-31End: 2017-03-31Updated: 2018-01-23

Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

Active, not recruitingNCT01717131

Institut Paoli-CalmettesInvasive Breast Cancer

Start: 2012-07-19End: 2031-09-30Updated: 2024-01-11

Related Papers

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.

2018-12-04108 citations

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node.

2018-11-2115 citations

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

2018-09-05363 citations

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

2013-03-11818 citations